159 related articles for article (PubMed ID: 1830628)
21. Differential production of deoxyadenosine by human T and B lymphoblasts.
Iizasa T; Kubota M; Carson DA
J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
[TBL] [Abstract][Full Text] [Related]
22. Adenosine- and deoxyadenosine-mediated altered pyrimidine metabolism in human adeosine deaminase-deficient lymphoblasts.
Parker NF; Jack I; Van Der Weyden MB
J Lab Clin Med; 1982 May; 99(5):731-9. PubMed ID: 6175708
[TBL] [Abstract][Full Text] [Related]
23. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth.
Slabaugh MB; Howell ML; Wang Y; Mathews CK
J Virol; 1991 May; 65(5):2290-8. PubMed ID: 2016760
[TBL] [Abstract][Full Text] [Related]
24. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
25. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
Matsumoto M; Tihan T; Cory JG
Cancer Chemother Pharmacol; 1990; 26(5):323-9. PubMed ID: 2208572
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
27. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
Cory JG; Carter GL
Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of two components and association of adenosine diphosphate-cytidine diphosphate reductase from cultured human lymphoblast cells (Molt-4F).
Chang CH; Cheng YC
Cancer Res; 1979 Feb; 39(2 Pt 1):436-42. PubMed ID: 570093
[No Abstract] [Full Text] [Related]
29. Cytidine 5'-diphosphate reductase activity in phytohemagglutinin stimulated human lymphocytes.
Tyrsted G; Gamulin V
Nucleic Acids Res; 1979 Jan; 6(1):305-19. PubMed ID: 424294
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
Lewis WH; McNaughton DR; Goh SH; LéJohn HB; Wright JA
J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
[TBL] [Abstract][Full Text] [Related]
31. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
32. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
33. Adenosine-mediated killing of cultured epithelial cancer cells.
Barry CP; Lind SE
Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
[TBL] [Abstract][Full Text] [Related]
34. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
Thuillier L; Garreau F; Cartier PH
Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
[TBL] [Abstract][Full Text] [Related]
35. Deoxyadenosine blockade of G0 to G1 transition in lymphocytes: possible involvement of protein kinases.
Sato T; Chan TS
J Cell Physiol; 1996 Feb; 166(2):288-95. PubMed ID: 8591988
[TBL] [Abstract][Full Text] [Related]
36. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
Kang GJ; Kimball AP
Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
[TBL] [Abstract][Full Text] [Related]
37. The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts.
Carson DA; Kaye J; Wasson DB
J Immunol; 1981 Jan; 126(1):348-52. PubMed ID: 6256438
[TBL] [Abstract][Full Text] [Related]
38. The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development.
Tsui M; Min W; Ng S; Dobbs K; Notarangelo LD; Dror Y; Grunebaum E
Front Immunol; 2021; 12():748519. PubMed ID: 34777360
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase.
Carter GL; Thompson DP; Cory JG
Cancer Commun; 1989; 1(1):13-20. PubMed ID: 2701080
[TBL] [Abstract][Full Text] [Related]
40. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
Dahbo Y; Eriksson S
Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
